Wyncore Retains Findit, Inc. to Improve Overall Web Presence and Exposure Throughout Social Media
September 22, 2020 at 03:07 pm
Share
Findit, Inc. has been retained by WynCore to improve overall web presence and exposure throughout social media. WynCore has engaged Findit to help improve overall online exposure throughout search and social media with a customized marketing campaign. Findit will produce fresh content on a daily basis highlighting WynCore and their professional warehouse management systems solutions. WynCore customized solutions covers: design and implementation, QA Testing, customized maintenance and support, and more. They can craft your WMS to suit your business and its needs. As part of their campaign, Findit will create, post, and share freshly written content through the Findit URLs that WynCore has claimed as part of their marketing campaign with Findit utilizing the Claim your Name Feature. Findit is currently in the process of setting up these Findit URLs. The content created will consist of Right Now status updates. Once the posts are live, they can be shared to other social networking sites that include but are not limited to: Facebook, LinkedIn, Pinterest, Tumblr, and Twitter. Findit will also be producing videos highlighting the services WynCore provides.
BioRegenx, Inc., formerly Findit, Inc., operates as a holding company. The Company specializes in acquiring intellectual property (IP) and companies engaged in regenerative biotherapeutics and anti-aging research. Its primary focus involves acquiring and developing non-invasive medical and wellness devices capable of efficiently recording, storing, and analyzing datasets. The Companyâs patented technologies and solutions include GlycoCheck, a high-definition video imaging that analyzes five parameters of microvascular health non-invasively with an under the tongue test using patented technology; Endocalyx Pro, an all-natural, plant-based patented nutraceutical shown to restore, regenerate, and protect microvascular health. Clinically tested in multiple double-blind placebo studies, and DocSun, an artificial intelligence using three advanced facial recognition technologies that analyzes 21 vital signs and health indicators without physical contact.